| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.857 | 0.009 | 0.903 | Antiinflammatory | 0.903 0.005 CID_154699616 | CID_154699616 | |
| 0.699 | 0.003 | 0.699 | Amyloid beta precursor protein antagonist | 0.416 0.005 CID_154699616 | ||
| 0.648 | 0.004 | 0.898 | Non-steroidal antiinflammatory agent | 0.898 0.003 CID_154699616 | CID_154699616 | |
| 0.645 | 0.004 | 0.645 | Cyclooxygenase 1 inhibitor | 0.429 0.006 CID_154699616 | ||
| 0.632 | 0.022 | 0.632 | Analgesic | 0.318 0.128 CID_154699616 | ||
| 0.595 | 0.008 | 0.677 | Antiamyloidogenic | 0.677 0.005 CID_154699616 | CID_154699616 | |
| 0.599 | 0.027 | 0.837 | Cyclophilin D inhibitor | 0.837 0.005 CID_154699616 | CID_154699616 | |
| 0.515 | 0.007 | 0.515 | Anesthetic general | 0.477 0.009 CID_154699616 | ||
| 0.526 | 0.029 | 0.688 | Cholesterol antagonist | 0.688 0.009 CID_154699616 | CID_154699616 | |
| 0.473 | 0.005 | 0.473 | Cyclooxygenase inhibitor | 0.347 0.011 CID_154699616 | ||
| 0.471 | 0.005 | 0.471 | Chelator | 0.21 0.023 CID_154699616 | ||
| 0.481 | 0.023 | 0.481 | Nootropic | |||
| 0.468 | 0.017 | 0.468 | Amyloid beta aggregation inhibitor | 0.334 0.038 CID_154699616 | ||
| 0.45 | 0.019 | 0.45 | Superoxide dismutase inhibitor | |||
| 0.442 | 0.022 | 0.704 | Hypoglycemic | 0.704 0.005 CID_154699616 | CID_154699616 | |
| 0.42 | 0.012 | 0.42 | Sodium/bile acid cotransporter inhibitor | 0.36 0.034 CID_154699616 | ||
| 0.423 | 0.017 | 0.423 | Calcium channel activator | 0.206 0.204 CID_154699616 | ||
| 0.457 | 0.052 | 0.732 | Transcription factor NF kappa B inhibitor | 0.732 0.017 CID_154699616 | CID_154699616 | |
| 0.386 | 0.004 | 0.73 | Cyclooxygenase 3 inhibitor | 0.73 0.001 CID_154699616 | CID_154699616 | |
| 0.382 | 0.008 | 0.394 | Interleukin 6 antagonist | 0.394 0.008 CID_154699616 | CID_154699616 | |
| 0.397 | 0.026 | 0.441 | Hypolipemic | 0.441 0.019 CID_154699616 | CID_154699616 | |
| 0.412 | 0.058 | 0.542 | Immunosuppressant | 0.542 0.022 CID_154699616 | CID_154699616 | |
| 0.349 | 0.004 | 0.349 | Alcohol dehydrogenase inhibitor | 0.225 0.01 CID_154699616 | ||
| 0.36 | 0.023 | 0.36 | 5 Hydroxytryptamine uptake stimulant | |||
| 0.378 | 0.043 | 0.378 | Lipoxygenase inhibitor | |||
| 0.338 | 0.009 | 0.338 | Cyclooxygenase 2 inhibitor | 0.247 0.02 CID_154699616 | ||
| 0.369 | 0.041 | 0.626 | Antioxidant | 0.626 0.01 CID_154699616 | CID_154699616 | |
| 0.424 | 0.097 | 0.424 | Caspase 9 stimulant | 0.397 0.113 CID_154699616 | ||
| 0.355 | 0.038 | 0.355 | Interleukin antagonist | 0.18 0.096 CID_154699616 | ||
| 0.327 | 0.022 | 0.327 | Tyrosine 3 hydroxylase inhibitor | |||
| 0.309 | 0.011 | 0.309 | Aldehyde dehydrogenase inhibitor | 0.229 0.022 CID_154699616 | ||
| 0.293 | 0.007 | 0.467 | ATPase inhibitor | 0.467 0.003 CID_154699616 | CID_154699616 | |
| 0.295 | 0.013 | 0.423 | Insulin secretagoues | 0.423 0.005 CID_154699616 | CID_154699616 | |
| 0.296 | 0.014 | 0.296 | Histone acetyltransferase inhibitor | |||
| 0.342 | 0.062 | 0.572 | Immunomodulator | 0.572 0.014 CID_154699616 | CID_154699616 | |
| 0.321 | 0.046 | 0.542 | Free radical scavenger | 0.542 0.012 CID_154699616 | CID_154699616 | |
| 0.309 | 0.036 | 0.309 | Peroxidase inhibitor | |||
| 0.359 | 0.097 | 0.658 | Antibacterial | 0.658 0.012 CID_154699616 | CID_154699616 | |
| 0.322 | 0.061 | 0.322 | Aldehyde oxidase inhibitor | |||
| 0.295 | 0.037 | 0.295 | Gastrin inhibitor | 0.246 0.083 CID_154699616 | ||
| 0.277 | 0.021 | 0.371 | NOS3 expression enhancer | 0.371 0.01 CID_154699616 | CID_154699616 | |
| 0.353 | 0.098 | 0.436 | Histamine release inhibitor | 0.436 0.057 CID_154699616 | CID_154699616 | |
| 0.323 | 0.075 | 0.712 | Antithrombotic | 0.712 0.008 CID_154699616 | CID_154699616 | |
| 0.244 | 0.006 | 0.244 | Interleukin 8 antagonist | 0.114 0.07 CID_154699616 | ||
| 0.305 | 0.07 | 0.431 | Interleukin 2 agonist | 0.431 0.019 CID_154699616 | CID_154699616 | |
| 0.26 | 0.031 | 0.391 | Thrombolytic | 0.391 0.012 CID_154699616 | CID_154699616 | |
| 0.236 | 0.009 | 0.236 | Arachidonic acid antagonist | 0.185 0.048 CID_154699616 | ||
| 0.242 | 0.02 | 0.242 | Interleukin 1 antagonist | 0.152 0.056 CID_154699616 | ||
| 0.28 | 0.059 | 0.396 | Interleukin agonist | 0.396 0.019 CID_154699616 | CID_154699616 | |
| 0.228 | 0.01 | 0.228 | Potassium channel (Ca-activated) activator | |||
| 0.265 | 0.048 | 0.453 | Nitric oxide antagonist | 0.453 0.02 CID_154699616 | CID_154699616 | |
| 0.248 | 0.034 | 0.248 | Lipocortins synthesis antagonist | 0.199 0.057 CID_154699616 | ||
| 0.335 | 0.129 | 0.335 | Calcium channel L-type activator | |||
| 0.212 | 0.007 | 0.212 | Sphingosine 1-phosphate receptor 5 antagonist | |||
| 0.243 | 0.043 | 0.244 | Neurotrophic factor enhancer | 0.244 0.042 CID_154699616 | CID_154699616 | |
| 0.224 | 0.028 | 0.321 | Alpha-N-acetylglucosaminidase inhibitor | 0.321 0.014 CID_154699616 | CID_154699616 | |
| 0.275 | 0.08 | 0.308 | Hypoxia-inducible factor 1 alpha inhibitor | 0.308 0.062 CID_154699616 | CID_154699616 | |
| 0.197 | 0.004 | 0.197 | Liver X receptor alpha agonist | |||
| 0.201 | 0.013 | 0.201 | Mucolytic | 0.189 0.016 CID_154699616 | ||
| 0.233 | 0.046 | 0.233 | Nitric-oxide synthase stimulant | 0.233 0.046 CID_154699616 | ||
| 0.194 | 0.007 | 0.194 | DOPA decarboxylase inhibitor | |||
| 0.214 | 0.028 | 0.365 | Hexokinase inhibitor | 0.365 0.005 CID_154699616 | CID_154699616 | |
| 0.22 | 0.035 | 0.22 | Succinate dehydrogenase inhibitor | |||
| 0.213 | 0.03 | 0.424 | Monophenol monooxygenase inhibitor | 0.424 0.01 CID_154699616 | CID_154699616 | |
| 0.193 | 0.013 | 0.193 | HIV-1 integrase (Overall Integration) inhibitor | |||
| 0.203 | 0.024 | 0.203 | Cystathionine beta-synthase inhibitor | 0.141 0.045 CID_154699616 | ||
| 0.215 | 0.036 | 0.357 | Interferon gamma antagonist | 0.357 0.013 CID_154699616 | CID_154699616 | |
| 0.204 | 0.026 | 0.204 | Cholesterol synthesis inhibitor | 0.134 0.054 CID_154699616 | ||
| 0.196 | 0.019 | 0.196 | GABA receptor agonist | |||
| 0.188 | 0.011 | 0.188 | Sphingosine 1-phosphate receptor 2 antagonist | |||
| 0.216 | 0.039 | 0.216 | Antipruritic | 0.133 0.118 CID_154699616 | ||
| 0.186 | 0.011 | 0.186 | ABCA1 expression enhancer | 0.093 0.061 CID_154699616 | ||
| 0.187 | 0.014 | 0.187 | Estrogen antagonist | 0.102 0.094 CID_154699616 | ||
| 0.318 | 0.145 | 0.346 | 5 Hydroxytryptamine release inhibitor | 0.346 0.118 CID_154699616 | CID_154699616 | |
| 0.182 | 0.009 | 0.182 | Macrophage migration inhibitory factor inhibitor | |||
| 0.276 | 0.103 | 0.441 | Apoptosis antagonist | 0.441 0.029 CID_154699616 | CID_154699616 | |
| 0.191 | 0.019 | 0.229 | Beta amyloid protein antagonist | 0.229 0.01 CID_154699616 | CID_154699616 | |
| 0.186 | 0.016 | 0.186 | GABA C receptor antagonist | |||
| 0.208 | 0.039 | 0.208 | Phospholipase C inhibitor | 0.167 0.077 CID_154699616 | ||
| 0.195 | 0.026 | 0.195 | Toll-Like receptor 2 antagonist | |||
| 0.172 | 0.004 | 0.172 | CXC chemokine 1 receptor antagonist | 0.052 0.034 CID_154699616 | ||
| 0.182 | 0.014 | 0.182 | Creatine kinase inhibitor | |||
| 0.2 | 0.041 | 0.328 | Protein kinase stimulant | 0.328 0.014 CID_154699616 | CID_154699616 | |
| 0.166 | 0.007 | 0.166 | Glycine transporter 2 inhibitor | |||
| 0.181 | 0.025 | 0.451 | Expectorant | 0.451 0.004 CID_154699616 | CID_154699616 | |
| 0.194 | 0.038 | 0.194 | Neurotensin receptor agonist | |||
| 0.163 | 0.012 | 0.163 | Keratolytic | |||
| 0.158 | 0.011 | 0.158 | Estrogen receptor alpha antagonist | |||
| 0.155 | 0.009 | 0.165 | Glutamate release inhibitor | 0.165 0.007 CID_154699616 | CID_154699616 | |
| 0.149 | 0.004 | 0.149 | GABA B receptor agonist | |||
| 0.162 | 0.017 | 0.28 | Triose-phosphate isomerase inhibitor | 0.28 0.005 CID_154699616 | CID_154699616 | |
| 0.168 | 0.028 | 0.168 | Pregnane X receptor agonist | |||
| 0.154 | 0.015 | 0.154 | Estrogen receptor beta antagonist | |||
| 0.225 | 0.088 | 0.358 | DNA synthesis inhibitor | 0.358 0.029 CID_154699616 | CID_154699616 | |
| 0.205 | 0.068 | 0.205 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | |||
| 0.186 | 0.05 | 0.186 | Phospholipase A2 inhibitor | 0.136 0.091 CID_154699616 | ||
| 0.147 | 0.012 | 0.147 | Lanosterol 14 alpha demethylase inhibitor | |||
| 0.177 | 0.044 | 0.185 | Mannose-6-phosphate isomerase inhibitor | 0.185 0.039 CID_154699616 | CID_154699616 | |
| 0.165 | 0.033 | 0.165 | 5-Lipoxygenase inhibitor | |||
| 0.141 | 0.009 | 0.141 | Bile acid receptor antagonist | 0.097 0.055 CID_154699616 | ||
| 0.18 | 0.051 | 0.307 | Melanin inhibitor | 0.307 0.021 CID_154699616 | CID_154699616 | |
| 0.154 | 0.026 | 0.435 | AMP-activated protein kinase stimulant | 0.435 0.004 CID_154699616 | CID_154699616 | |
| 0.15 | 0.022 | 0.15 | Prolactin inhibitor | |||
| 0.155 | 0.028 | 0.155 | TRPA1 agonist | |||
| 0.159 | 0.034 | 0.159 | Ferrochelatase inhibitor | |||
| 0.157 | 0.032 | 0.157 | Vanilloid 1 agonist | 0.14 0.051 CID_154699616 | ||
| 0.149 | 0.026 | 0.149 | Catalase inhibitor | |||
| 0.174 | 0.053 | 0.399 | Amylase inhibitor | 0.399 0.009 CID_154699616 | CID_154699616 | |
| 0.127 | 0.008 | 0.127 | Estrogen-related receptor beta agonist | |||
| 0.139 | 0.021 | 0.158 | Thioredoxin inhibitor | 0.158 0.014 CID_154699616 | CID_154699616 | |
| 0.135 | 0.019 | 0.135 | Glutamate (mGluR7) agonist | |||
| 0.158 | 0.044 | 0.158 | Farnesoid X receptor antagonist | |||
| 0.219 | 0.106 | 0.298 | Spasmolytic | 0.298 0.071 CID_154699616 | CID_154699616 | |
| 0.117 | 0.004 | 0.117 | Liver X receptor beta agonist | |||
| 0.116 | 0.004 | 0.116 | Nicotinic acid receptor agonist | |||
| 0.126 | 0.016 | 0.126 | Phenylalanine 4-hydroxylase inhibitor | |||
| 0.196 | 0.086 | 0.196 | Anticonvulsant | |||
| 0.257 | 0.148 | 0.257 | GABA C receptor rho-3 antagonist | |||
| 0.127 | 0.018 | 0.127 | Glutamate decarboxylase inhibitor | |||
| 0.122 | 0.014 | 0.123 | Aldose reductase inhibitor | 0.123 0.014 CID_154699616 | CID_154699616 | |
| 0.289 | 0.181 | 0.534 | Apoptosis agonist | 0.534 0.064 CID_154699616 | CID_154699616 | |
| 0.12 | 0.013 | 0.12 | Sphingosine 1-phosphate receptor antagonist | |||
| 0.121 | 0.014 | 0.121 | Alcohol oxidase inhibitor | |||
| 0.137 | 0.031 | 0.17 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.17 0.021 CID_154699616 | CID_154699616 | |
| 0.123 | 0.018 | 0.123 | Prostaglandin-E synthase inhibitor | |||
| 0.149 | 0.046 | 0.149 | Ca2+-transporting ATPase inhibitor | 0.141 0.069 CID_154699616 | ||
| 0.143 | 0.041 | 0.143 | Papain-like protease (SARS coronavirus) inhibitor | |||
| 0.159 | 0.057 | 0.302 | Cell wall synthesis inhibitor | 0.302 0.01 CID_154699616 | CID_154699616 | |
| 0.106 | 0.005 | 0.106 | DNA helicase inhibitor | 0.074 0.014 CID_154699616 | ||
| 0.126 | 0.024 | 0.126 | Glutamate receptor agonist | |||
| 0.116 | 0.017 | 0.116 | HIV-1 integrase inhibitor | |||
| 0.102 | 0.004 | 0.102 | Glucagon receptor antagonist | |||
| 0.099 | 0.005 | 0.099 | AICAR transformylase inhibitor | 0.041 0.036 CID_154699616 | ||
| 0.135 | 0.041 | 0.135 | GABA C receptor agonist | |||
| 0.107 | 0.013 | 0.107 | Peroxisome proliferator-activated receptor gamma antagonist | |||
| 0.153 | 0.059 | 0.153 | MAO inhibitor | |||
| 0.098 | 0.004 | 0.098 | Glutamate (mGluR3) antagonist | |||
| 0.135 | 0.042 | 0.183 | Photosensitizer | 0.183 0.017 CID_154699616 | CID_154699616 | |
| 0.102 | 0.01 | 0.102 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | |||
| 0.107 | 0.015 | 0.107 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.088 0.021 CID_154699616 | ||
| 0.12 | 0.028 | 0.12 | Porphobilinogen synthase inhibitor | |||
| 0.143 | 0.051 | 0.34 | Cell adhesion inhibitor | 0.34 0.008 CID_154699616 | CID_154699616 | |
| 0.132 | 0.041 | 0.132 | Nav1.1 sodium channel blocker | |||
| 0.241 | 0.155 | 0.241 | Toll-Like receptor 7 agonist | |||
| 0.107 | 0.023 | 0.107 | GABA aminotransferase inhibitor | 0.081 0.046 CID_154699616 | ||
| 0.171 | 0.088 | 0.418 | Hepatoprotectant | 0.418 0.012 CID_154699616 | CID_154699616 | |
| 0.114 | 0.031 | 0.114 | NAD(P)H dehydrogenase (quinone) inhibitor | |||
| 0.103 | 0.02 | 0.103 | Leukotriene antagonist | 0.082 0.031 CID_154699616 | ||
| 0.091 | 0.009 | 0.091 | Kinesin antagonist | |||
| 0.091 | 0.009 | 0.091 | Kinesin-like protein 1 inhibitor | |||
| 0.092 | 0.009 | 0.092 | Diacylglycerol O-acyltransferase inhibitor | |||
| 0.099 | 0.017 | 0.099 | Estrogen agonist | 0.061 0.03 CID_154699616 | ||
| 0.244 | 0.162 | 0.341 | Antiobesity | 0.341 0.092 CID_154699616 | CID_154699616 | |
| 0.084 | 0.004 | 0.084 | Liver X receptor beta antagonist | |||
| 0.104 | 0.026 | 0.104 | Peroxisome proliferator-activated receptor gamma agonist | 0.072 0.047 CID_154699616 | ||
| 0.1 | 0.024 | 0.1 | Potassium channel large-conductance Ca-activated activator | |||
| 0.088 | 0.012 | 0.088 | Sphingosine 1-phosphate receptor 3 antagonist | |||
| 0.1 | 0.024 | 0.1 | Amidase inhibitor | |||
| 0.236 | 0.161 | 0.236 | Toll-Like receptor agonist | 0.216 0.183 CID_154699616 | ||
| 0.079 | 0.004 | 0.079 | Free fatty acid receptor 1 antagonist | |||
| 0.175 | 0.101 | 0.175 | Insulin sensitizer | 0.146 0.138 CID_154699616 | ||
| 0.085 | 0.011 | 0.085 | CD45 antagonist | |||
| 0.115 | 0.041 | 0.139 | Uric acid excretion stimulant | 0.139 0.028 CID_154699616 | CID_154699616 | |
| 0.092 | 0.019 | 0.092 | Prostaglandin antagonist | |||
| 0.196 | 0.124 | 0.196 | 5 Hydroxytryptamine release stimulant | |||
| 0.132 | 0.06 | 0.151 | DNA polymerase I inhibitor | 0.151 0.049 CID_154699616 | CID_154699616 | |
| 0.102 | 0.031 | 0.102 | Vanilloid agonist | |||
| 0.078 | 0.008 | 0.078 | Retinoid X receptor agonist | |||
| 0.075 | 0.006 | 0.075 | Dopamine beta hydroxylase inhibitor | |||
| 0.085 | 0.016 | 0.085 | Peroxisome proliferator-activated receptor alpha agonist | |||
| 0.112 | 0.043 | 0.112 | MAP kinase kinase 1 inhibitor | |||
| 0.08 | 0.013 | 0.08 | Oleamide hydrolase inhibitor | |||
| 0.098 | 0.032 | 0.098 | D-Ala-D-Ala ligase inhibitor | |||
| 0.127 | 0.062 | 0.243 | Topoisomerase II inhibitor | 0.243 0.025 CID_154699616 | CID_154699616 | |
| 0.104 | 0.04 | 0.104 | Ornithine decarboxylase inhibitor | |||
| 0.096 | 0.032 | 0.096 | Purinergic P2X2 antagonist | |||
| 0.124 | 0.06 | 0.136 | Protein-tyrosine phosphatase 1B inhibitor | 0.136 0.052 CID_154699616 | CID_154699616 | |
| 0.072 | 0.009 | 0.072 | Retinoid X alpha receptor agonist | |||
| 0.213 | 0.15 | 0.271 | Caspase 3 stimulant | 0.271 0.096 CID_154699616 | CID_154699616 | |
| 0.077 | 0.015 | 0.077 | Estrogen receptor beta agonist | |||
| 0.07 | 0.008 | 0.07 | AMPA 4 receptor antagonist | |||
| 0.185 | 0.123 | 0.185 | RNA-directed DNA polymerase inhibitor | |||
| 0.098 | 0.036 | 0.216 | Cell adhesion molecule inhibitor | 0.216 0.008 CID_154699616 | CID_154699616 | |
| 0.145 | 0.084 | 0.145 | Protein-tyrosine phosphatase inhibitor | 0.14 0.09 CID_154699616 | ||
| 0.207 | 0.146 | 0.207 | Insulysin inhibitor | |||
| 0.074 | 0.015 | 0.074 | NMDA receptor subunit 3B antagonist | |||
| 0.07 | 0.01 | 0.07 | Urate transporter 1 inhibitor | |||
| 0.072 | 0.013 | 0.072 | Estrogen receptor alpha agonist | |||
| 0.092 | 0.033 | 0.116 | T cell inhibitor | 0.116 0.015 CID_154699616 | CID_154699616 | |
| 0.064 | 0.005 | 0.064 | Retinoid X receptor antagonist | |||
| 0.088 | 0.03 | 0.088 | Glycine receptor agonist | 0.071 0.052 CID_154699616 | ||
| 0.077 | 0.019 | 0.077 | Dihydroorotate dehydrogenase inhibitor | |||
| 0.062 | 0.005 | 0.062 | ATP citrate lysase inhibitor | |||
| 0.113 | 0.057 | 0.113 | Aminopeptidase B inhibitor | |||
| 0.203 | 0.148 | 0.203 | 12-Lipoxygenase inhibitor | |||
| 0.058 | 0.005 | 0.058 | Free fatty acid receptor 1 agonist | |||
| 0.117 | 0.065 | 0.117 | Caspase 3 inhibitor | |||
| 0.099 | 0.048 | 0.099 | NMDA receptor antagonist | |||
| 0.067 | 0.017 | 0.067 | Estradiol 17 beta-dehydrogenase inhibitor | |||
| 0.055 | 0.005 | 0.055 | CXC chemokine 2 receptor antagonist | |||
| 0.065 | 0.016 | 0.254 | Heparanase inhibitor | 0.254 0.002 CID_154699616 | CID_154699616 | |
| 0.053 | 0.005 | 0.053 | Retinoid X alpha receptor antagonist | |||
| 0.063 | 0.017 | 0.063 | Secretase gamma inhibitor | |||
| 0.106 | 0.06 | 0.166 | Toll-Like receptor 4 antagonist | 0.166 0.014 CID_154699616 | CID_154699616 | |
| 0.103 | 0.058 | 0.103 | MAO B inhibitor | |||
| 0.075 | 0.03 | 0.075 | Glutamate (mGluR6) antagonist | |||
| 0.084 | 0.039 | 0.084 | CDC25A inhibitor | |||
| 0.079 | 0.036 | 0.079 | Phospholipase D inhibitor | |||
| 0.054 | 0.011 | 0.054 | Peroxisome proliferator-activated receptor delta agonist | |||
| 0.072 | 0.03 | 0.09 | Nitric oxide donor | 0.09 0.015 CID_154699616 | CID_154699616 | |
| 0.102 | 0.06 | 0.102 | Anabolic | |||
| 0.101 | 0.059 | 0.153 | Xanthine oxidase inhibitor | 0.153 0.033 CID_154699616 | CID_154699616 | |
| 0.064 | 0.023 | 0.064 | Aconitate hydratase inhibitor | |||
| 0.134 | 0.093 | 0.134 | Adenylate cyclase stimulant | |||
| 0.048 | 0.008 | 0.048 | Peroxisome proliferator-activated receptor alpha antagonist | |||
| 0.057 | 0.018 | 0.057 | Liver X receptor agonist | |||
| 0.053 | 0.014 | 0.053 | Estradiol 17 beta-dehydrogenase 2 inhibitor | |||
| 0.05 | 0.012 | 0.05 | Glutamate (mGluR8) agonist | |||
| 0.122 | 0.084 | 0.122 | Bone formation stimulant | |||
| 0.102 | 0.065 | 0.102 | Urease inhibitor | |||
| 0.06 | 0.022 | 0.06 | Topoisomerase II beta inhibitor | |||
| 0.1 | 0.064 | 0.1 | Folate antagonist | 0.099 0.066 CID_154699616 | ||
| 0.047 | 0.011 | 0.047 | AMPA receptor agonist | |||
| 0.041 | 0.006 | 0.041 | Thyroid hormone agonist | |||
| 0.087 | 0.052 | 0.087 | GABA A receptor agonist | |||
| 0.11 | 0.075 | 0.11 | Adenylate cyclase inhibitor | |||
| 0.044 | 0.01 | 0.044 | Cholesterol ester transfer protein antagonist | |||
| 0.062 | 0.027 | 0.062 | Pregnane X receptor antagonist | |||
| 0.042 | 0.008 | 0.042 | Liver X receptor alpha antagonist | |||
| 0.037 | 0.004 | 0.037 | G-protein-coupled receptor 120 agonist | |||
| 0.101 | 0.069 | 0.192 | Mediator release inhibitor | 0.192 0.016 CID_154699616 | CID_154699616 | |
| 0.077 | 0.045 | 0.077 | Aminopeptidase I inhibitor | |||
| 0.047 | 0.015 | 0.047 | Nicotinic acid receptor 2 agonist | |||
| 0.07 | 0.038 | 0.07 | CDC25B inhibitor | |||
| 0.051 | 0.019 | 0.051 | NMDA receptor subunit 3A antagonist | |||
| 0.048 | 0.017 | 0.048 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | |||
| 0.07 | 0.039 | 0.07 | MDM2 inhibitor | |||
| 0.04 | 0.009 | 0.04 | Glutamate (mGluR3) agonist | |||
| 0.043 | 0.012 | 0.043 | HMG CoA reductase inhibitor | 0.037 0.019 CID_154699616 | ||
| 0.146 | 0.115 | 0.146 | Catenin beta inhibitor | |||
| 0.097 | 0.066 | 0.097 | MAO A inhibitor | |||
| 0.11 | 0.08 | 0.11 | Transcription factor STAT6 inhibitor | |||
| 0.066 | 0.036 | 0.07 | Transcription factor AP-1 inhibitor | 0.07 0.03 CID_154699616 | CID_154699616 | |
| 0.042 | 0.013 | 0.042 | Liver X receptor antagonist | |||
| 0.047 | 0.018 | 0.047 | Glutamate (mGluR group II) antagonist | |||
| 0.033 | 0.004 | 0.033 | Nicotinic acid receptor 1 antagonist | |||
| 0.072 | 0.043 | 0.072 | Leukotriene synthesis inhibitor | |||
| 0.098 | 0.07 | 0.098 | Adenylate kinase inhibitor | |||
| 0.06 | 0.032 | 0.06 | Thromboxane antagonist | |||
| 0.07 | 0.043 | 0.07 | Glutamate (mGluR7) antagonist | |||
| 0.052 | 0.026 | 0.052 | Cholesterol esterase inhibitor | |||
| 0.057 | 0.031 | 0.072 | Leukotriene B4 antagonist | 0.072 0.018 CID_154699616 | CID_154699616 | |
| 0.087 | 0.062 | 0.135 | NADH dehydrogenase inhibitor | 0.135 0.022 CID_154699616 | CID_154699616 | |
| 0.05 | 0.025 | 0.05 | Sphingosine 1-phosphate receptor agonist | |||
| 0.049 | 0.026 | 0.049 | Dihydroorotase inhibitor | |||
| 0.043 | 0.02 | 0.043 | Farnesoid X receptor agonist | |||
| 0.041 | 0.019 | 0.041 | Vanilloid 3 antagonist | |||
| 0.033 | 0.011 | 0.033 | Estrogen-related receptor gamma antagonist | |||
| 0.062 | 0.04 | 0.062 | Aromatase inhibitor | |||
| 0.033 | 0.011 | 0.033 | Estradiol 17 beta-dehydrogenase 1 inhibitor | |||
| 0.099 | 0.077 | 0.099 | Nav1.4 sodium channel blocker | |||
| 0.046 | 0.024 | 0.046 | Sphingosine 1-phosphate receptor 1 agonist | |||
| 0.038 | 0.016 | 0.038 | Melatonin receptor 1A agonist | |||
| 0.092 | 0.07 | 0.135 | Phosphodiesterase 6D inhibitor | 0.135 0.015 CID_154699616 | CID_154699616 | |
| 0.043 | 0.022 | 0.043 | G protein-coupled receptor agonist | |||
| 0.059 | 0.039 | 0.059 | Botulinum neurotoxin type A inhibitor | |||
| 0.069 | 0.049 | 0.128 | Phosphofructokinase-1 inhibitor | 0.128 0.023 CID_154699616 | CID_154699616 | |
| 0.031 | 0.011 | 0.031 | Prostaglandin D2 antagonist | |||
| 0.061 | 0.041 | 0.061 | TRPA1 antagonist | |||
| 0.031 | 0.011 | 0.031 | Retinoid X gamma receptor antagonist | |||
| 0.139 | 0.12 | 0.386 | Platelet adhesion inhibitor | 0.386 0.013 CID_154699616 | CID_154699616 | |
| 0.044 | 0.025 | 0.044 | DNA gyrase subunit A inhibitor | |||
| 0.132 | 0.113 | 0.132 | Heat shock protein 70 antagonist | 0.132 0.112 CID_154699616 | ||
| 0.062 | 0.044 | 0.062 | Prostaglandin F2 alpha antagonist | |||
| 0.069 | 0.052 | 0.069 | Histidine decarboxylase inhibitor | |||
| 0.056 | 0.04 | 0.056 | Leukotriene C antagonist | |||
| 0.034 | 0.018 | 0.034 | Prostaglandin agonist | |||
| 0.058 | 0.043 | 0.058 | Androgen agonist | |||
| 0.023 | 0.009 | 0.023 | Retinoid X beta receptor antagonist | |||
| 0.036 | 0.022 | 0.036 | RNA-directed RNA polymerase inhibitor | |||
| 0.046 | 0.032 | 0.046 | Purinergic P2X4 antagonist | |||
| 0.044 | 0.03 | 0.044 | Glutamate (mGluR group III) antagonist | |||
| 0.055 | 0.042 | 0.055 | Xanthine dehydrogenase inhibitor | |||
| 0.06 | 0.046 | 0.06 | Heme oxygenase stimulant | |||
| 0.032 | 0.019 | 0.032 | Factor VII inhibitor | |||
| 0.032 | 0.019 | 0.032 | Prostaglandin D2 agonist | |||
| 0.02 | 0.007 | 0.02 | Thyroid hormone alpha agonist | |||
| 0.034 | 0.021 | 0.034 | Peroxisome proliferator-activated receptor delta antagonist | |||
| 0.047 | 0.034 | 0.062 | Glucose-6-phosphate isomerase inhibitor | 0.062 0.017 CID_154699616 | CID_154699616 | |
| 0.153 | 0.141 | 0.315 | Platelet antagonist | 0.315 0.048 CID_154699616 | CID_154699616 | |
| 0.036 | 0.024 | 0.036 | Glutamate (mGluR8) antagonist | |||
| 0.03 | 0.019 | 0.03 | Diacylglycerol O-acyltransferase 1 inhibitor | |||
| 0.067 | 0.055 | 0.067 | Secretase beta inhibitor | |||
| 0.053 | 0.042 | 0.053 | Epithelial sodium channel blocker | |||
| 0.069 | 0.058 | 0.069 | Glutamate dehydrogenase inhibitor | |||
| 0.056 | 0.045 | 0.056 | HIV-1 integrase (Strand Transfer) inhibitor | |||
| 0.041 | 0.03 | 0.041 | Kainate receptor agonist | |||
| 0.032 | 0.021 | 0.032 | HCV NS5B polymerase inhibitor | |||
| 0.022 | 0.012 | 0.022 | Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor | |||
| 0.027 | 0.017 | 0.027 | Nicotinic acid receptor 2 antagonist | |||
| 0.02 | 0.01 | 0.02 | Estrogen-related receptor gamma agonist | |||
| 0.099 | 0.089 | 0.196 | Alkylator | 0.196 0.027 CID_154699616 | CID_154699616 | |
| 0.087 | 0.078 | 0.173 | UDP-glucose 4-epimerase inhibitor | 0.173 0.022 CID_154699616 | CID_154699616 | |
| 0.059 | 0.05 | 0.059 | Caspase 9 inhibitor | |||
| 0.023 | 0.015 | 0.023 | Prostaglandin F2 alpha agonist | |||
| 0.027 | 0.018 | 0.027 | Lysine carboxypeptidase inhibitor | |||
| 0.041 | 0.033 | 0.041 | Macrophage elastase inhibitor | |||
| 0.04 | 0.032 | 0.04 | Carbonic anhydrase IV inhibitor | |||
| 0.052 | 0.044 | 0.052 | Thromboxane synthase inhibitor | |||
| 0.038 | 0.031 | 0.038 | Dopamine D5 agonist | |||
| 0.015 | 0.008 | 0.015 | Integrin beta6 antagonist | |||
| 0.022 | 0.016 | 0.022 | Prostaglandin EP2 agonist | |||
| 0.054 | 0.047 | 0.059 | Prostaglandin EP2 antagonist | 0.059 0.042 CID_154699616 | CID_154699616 | |
| 0.011 | 0.005 | 0.011 | Thyroid hormone beta agonist | |||
| 0.08 | 0.075 | 0.08 | Granulocyte macrophage colony stimulating factor agonist | |||
| 0.091 | 0.085 | 0.203 | Beta glucuronidase inhibitor | 0.203 0.012 CID_154699616 | CID_154699616 | |
| 0.022 | 0.017 | 0.022 | Prostaglandin E2 agonist | |||
| 0.035 | 0.03 | 0.035 | TRPM8 blocker | |||
| 0.075 | 0.07 | 0.075 | Glutathione S-transferase inhibitor | |||
| 0.015 | 0.01 | 0.015 | Calcium-sensing receptor antagonist | |||
| 0.014 | 0.009 | 0.014 | 5 Lipoxygenase activating protein inhibitor | |||
| 0.052 | 0.048 | 0.052 | Sphingosine 1-phosphate receptor 1 antagonist | |||
| 0.136 | 0.132 | 0.638 | Angiogenesis stimulant | 0.638 0.005 CID_154699616 | CID_154699616 | |
| 0.014 | 0.011 | 0.014 | Egl nine homolog 1 inhibitor | |||
| 0.026 | 0.023 | 0.026 | Hedgehog signaling activator | |||
| 0.111 | 0.109 | 0.111 | Nav1.6 sodium channel blocker | |||
| 0.02 | 0.019 | 0.02 | Glutamate (mGluR1a) agonist | |||
| 0.027 | 0.026 | 0.027 | Glutamate (mGluR2) antagonist | |||
| 0.084 | 0.083 | 0.084 | Interleukin 1 beta converting enzyme inhibitor | |||
| 0.069 | 0.068 | 0.069 | Metalloproteinase-2 inhibitor | |||
| 0.051 | 0.052 | 0.064 | Adenine nucleotide translocase inhibitor | 0.064 0.023 CID_154699616 | CID_154699616 | |
| 0.032 | 0.033 | 0.033 | Ceramide glucosyltransferase inhibitor | 0.033 0.03 CID_154699616 | CID_154699616 | |
| 0.013 | 0.017 | 0.038 | Ileal bile acid transport inhibitor | 0.038 0.004 CID_154699616 | CID_154699616 | |
| 0.078 | 0.082 | 0.123 | ATPase (Vacuolar H+) inhibitor | 0.123 0.018 CID_154699616 | CID_154699616 | |
| 0.095 | 0.1 | 0.122 | Microtubule formation inhibitor | 0.122 0.059 CID_154699616 | CID_154699616 | |
| 0.022 | 0.028 | 0.093 | Sodium/glucose cotransporter inhibitor | 0.093 0.003 CID_154699616 | CID_154699616 | |
| 0.022 | 0.03 | 0.102 | Sodium/glucose cotransporter 2 inhibitor | 0.102 0.003 CID_154699616 | CID_154699616 | |
| 0.115 | 0.126 | 0.397 | Hemostatic | 0.397 0.008 CID_154699616 | CID_154699616 | |
| 0.033 | 0.047 | 0.038 | Guanylate cyclase inhibitor | 0.038 0.036 CID_154699616 | CID_154699616 | |
| 0.101 | 0.115 | 0.233 | Lipid peroxidase inhibitor | 0.233 0.03 CID_154699616 | CID_154699616 | |
| 0.051 | 0.066 | 0.066 | Lipocortins synthesis agonist | 0.066 0.025 CID_154699616 | CID_154699616 | |
| 0.043 | 0.059 | 0.089 | Glucose-6-phosphate translocase inhibitor | 0.089 0.008 CID_154699616 | CID_154699616 | |
| 0.023 | 0.04 | 0.046 | Arginase inhibitor | 0.046 0.018 CID_154699616 | CID_154699616 | |
| 0.182 | 0.2 | 0.349 | Vasodilator, coronary | 0.349 0.056 CID_154699616 | CID_154699616 | |
| 0.08 | 0.1 | 0.107 | Interleukin 12 antagonist | 0.107 0.043 CID_154699616 | CID_154699616 | |
| 0.15 | 0.172 | 0.166 | DNA damaging | 0.166 0.15 CID_154699616 | CID_154699616 | |
| 0.011 | 0.035 | 0.016 | Telomerase stimulant | 0.016 0.015 CID_154699616 | CID_154699616 | |
| 0.118 | 0.149 | 0.183 | DNA methyltransferase I inhibitor | 0.183 0.078 CID_154699616 | CID_154699616 | |
| 0.018 | 0.05 | 0.028 | Vanilloid 2 agonist | 0.028 0.012 CID_154699616 | CID_154699616 | |
| 0.05 | 0.085 | 0.095 | Na+ K+ transporting ATPase inhibitor | 0.095 0.036 CID_154699616 | CID_154699616 | |
| 0.012 | 0.051 | 0.021 | Antibiotic Anthracycline-like | 0.021 0.009 CID_154699616 | CID_154699616 | |
| 0.013 | 0.054 | 0.023 | Dopamine D1 agonist | 0.023 0.015 CID_154699616 | CID_154699616 | |
| 0.037 | 0.08 | 0.078 | Alpha-mannosidase inhibitor | 0.078 0.012 CID_154699616 | CID_154699616 | |
| 0.025 | 0.069 | 0.073 | Phosphorylase inhibitor | 0.073 0.019 CID_154699616 | CID_154699616 | |
| 0.096 | 0.146 | 0.183 | DNA repair enzyme inhibitor | 0.183 0.012 CID_154699616 | CID_154699616 | |
| 0.056 | 0.11 | 0.098 | Glycine receptor antagonist | 0.098 0.034 CID_154699616 | CID_154699616 | |
| 0.047 | 0.105 | 0.114 | Topoisomerase II alpha inhibitor | 0.114 0.032 CID_154699616 | CID_154699616 | |
| 0.092 | 0.158 | 0.254 | Anticoagulant | 0.254 0.038 CID_154699616 | CID_154699616 | |
| 0.016 | 0.082 | 0.027 | 1,3-Beta-glucan synthase inhibitor | 0.027 0.024 CID_154699616 | CID_154699616 | |
| 0.024 | 0.091 | 0.068 | Mannosidase inhibitor | 0.068 0.012 CID_154699616 | CID_154699616 | |
| 0.12 | 0.188 | 0.408 | Immunostimulant | 0.408 0.047 CID_154699616 | CID_154699616 | |
| 0.009 | 0.081 | 0.034 | Squalene synthetase inhibitor | 0.034 0.021 CID_154699616 | CID_154699616 | |
| 0.026 | 0.099 | 0.1 | Protein 50S ribosomal subunit inhibitor | 0.1 0.013 CID_154699616 | CID_154699616 | |
| 0.036 | 0.112 | 0.046 | Factor III inhibitor | 0.046 0.045 CID_154699616 | CID_154699616 | |
| 0.099 | 0.195 | 0.187 | DNA methylase inhibitor | 0.187 0.088 CID_154699616 | CID_154699616 | |
| 0.136 | 0.238 | 0.356 | Peptidyltransferase inhibitor | 0.356 0.011 CID_154699616 | CID_154699616 | |
| 0.045 | 0.156 | 0.172 | Topoisomerase I inhibitor | 0.172 0.034 CID_154699616 | CID_154699616 | |
| 0.023 | 0.135 | 0.042 | Microtubule stabilization | 0.042 0.039 CID_154699616 | CID_154699616 | |
| 0.026 | 0.143 | 0.156 | Antineoplastic antibiotic | 0.156 0.03 CID_154699616 | CID_154699616 | |
| 0.024 | 0.145 | 0.335 | Selectin antagonist | 0.335 0.004 CID_154699616 | CID_154699616 | |
| 0.027 | 0.151 | 0.086 | Factor IXa inhibitor | 0.086 0.014 CID_154699616 | CID_154699616 | |
| 0.016 | 0.142 | 0.031 | Toll-Like receptor 4 agonist | 0.031 0.01 CID_154699616 | CID_154699616 | |
| 0.05 | 0.226 | 0.121 | Transcription factor NF kappa B stimulant | 0.121 0.025 CID_154699616 | CID_154699616 | |
| 0.099 | 0.287 | 0.136 | CC chemokine 6 receptor antagonist | 0.136 0.05 CID_154699616 | CID_154699616 | |
| 0.06 | 0.272 | 0.119 | Diuretic | 0.119 0.106 CID_154699616 | CID_154699616 | |
| 0.02 | 0.235 | 0.06 | Neuraminidase (influenza) inhibitor | 0.06 0.053 CID_154699616 | CID_154699616 | |
| 0.007 | 0.283 | 0.034 | Protein 30S ribosomal subunit inhibitor | 0.034 0.011 CID_154699616 | CID_154699616 | |
| 0.014 | 0.363 | 0.066 | Antibiotic Aminoglycoside-like | 0.066 0.007 CID_154699616 | CID_154699616 | |
| 0.04 | 0.476 | 0.32 | Tumour necrosis factor alpha release inhibitor | 0.32 0.046 CID_154699616 | CID_154699616 | |
| 0.05 | 0.491 | 0.194 | Angiogenesis inhibitor | 0.194 0.177 CID_154699616 | CID_154699616 | |
| 0.02 | 0.625 | 0.161 | Vasodilator | 0.161 0.141 CID_154699616 | CID_154699616 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |